Cilostazol has beneficial effects in treatment of intermittent claudication: results from a multicenter, randomized, prospective, double-blind trial. [electronic resource]
Producer: 19980909Description: 678-86 p. digitalISSN:- 0009-7322
- Adult
- Aged
- Arteriosclerosis -- complications
- Cholesterol -- blood
- Cholesterol, HDL -- blood
- Cholesterol, LDL -- blood
- Cilostazol
- Double-Blind Method
- Female
- Humans
- Intermittent Claudication -- blood
- Ischemia
- Leg -- blood supply
- Male
- Middle Aged
- Platelet Aggregation Inhibitors -- therapeutic use
- Prospective Studies
- Single-Blind Method
- Tetrazoles -- adverse effects
- Time Factors
- Triglycerides -- blood
- Vasodilator Agents -- adverse effects
- Walking
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.